The healthcare industry — from providers and health systems to payers — is increasingly adopting value-based care practices, which is not surprising given that approximately 61% of all healthcare payments are tied to value and quality in some way. In… Continue Reading
OM1 was founded by a team dedicated to the belief that participating in value-based healthcare requires a much more complete view of patient outcomes than what has been available until now. With that principle in mind, OM1 has built the… Continue Reading
The last decade has seen an explosion of interest in and production of real world evidence (RWE). But I’m afraid there is a day of reckoning approaching. Continue Reading
Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossie 2018). Its increasing prevalence parallels rising rates of obesity and type 2 diabetes. Continue Reading
The use of real-world data to generate RWE for medical devices by industry has become more prominent in recent years, and more attractive to a variety of stakeholders. It is used frequently to understand the use of the device in the larger clinical setting, but more recently it is also being used for regulatory decision making. Continue Reading
